
TBI Valuation
TrueBlue Inc
- Overview
- Forecast
- Valuation
- Earnings
TBI Relative Valuation
TBI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TBI is overvalued; if below, it's undervalued.
Historical Valuation
TrueBlue Inc (TBI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.13 is considered Undervalued compared with the five-year average of 15.41. The fair price of TrueBlue Inc (TBI) is between 14.53 to 24.31 according to relative valuation methord. Compared to the current price of 7.42 USD , TrueBlue Inc is Undervalued By 48.95%.
Relative Value
Fair Zone
14.53-24.31
Current Price:7.42
48.95%
Undervalued
-76.72
PE
1Y
3Y
5Y
Trailing
Forward
10.03
EV/EBITDA
TrueBlue Inc. (TBI) has a current EV/EBITDA of 10.03. The 5-year average EV/EBITDA is 25.66. The thresholds are as follows: Strongly Undervalued below -85.21, Undervalued between -85.21 and -29.77, Fairly Valued between 81.10 and -29.77, Overvalued between 81.10 and 136.54, and Strongly Overvalued above 136.54. The current Forward EV/EBITDA of 10.03 falls within the Historic Trend Line -Fairly Valued range.
-70.63
EV/EBIT
TrueBlue Inc. (TBI) has a current EV/EBIT of -70.63. The 5-year average EV/EBIT is 2.79. The thresholds are as follows: Strongly Undervalued below -62.66, Undervalued between -62.66 and -29.94, Fairly Valued between 35.52 and -29.94, Overvalued between 35.52 and 68.24, and Strongly Overvalued above 68.24. The current Forward EV/EBIT of -70.63 falls within the Strongly Undervalued range.
0.12
PS
TrueBlue Inc. (TBI) has a current PS of 0.12. The 5-year average PS is 0.28. The thresholds are as follows: Strongly Undervalued below 0.08, Undervalued between 0.08 and 0.18, Fairly Valued between 0.39 and 0.18, Overvalued between 0.39 and 0.49, and Strongly Overvalued above 0.49. The current Forward PS of 0.12 falls within the Undervalued range.
8.74
P/OCF
TrueBlue Inc. (TBI) has a current P/OCF of 8.74. The 5-year average P/OCF is 5.95. The thresholds are as follows: Strongly Undervalued below -49.41, Undervalued between -49.41 and -21.73, Fairly Valued between 33.63 and -21.73, Overvalued between 33.63 and 61.31, and Strongly Overvalued above 61.31. The current Forward P/OCF of 8.74 falls within the Historic Trend Line -Fairly Valued range.
87.78
P/FCF
TrueBlue Inc. (TBI) has a current P/FCF of 87.78. The 5-year average P/FCF is -5.56. The thresholds are as follows: Strongly Undervalued below -150.53, Undervalued between -150.53 and -78.04, Fairly Valued between 66.92 and -78.04, Overvalued between 66.92 and 139.41, and Strongly Overvalued above 139.41. The current Forward P/FCF of 87.78 falls within the Overvalued range.
TrueBlue Inc (TBI) has a current Price-to-Book (P/B) ratio of 0.70. Compared to its 3-year average P/B ratio of 0.94 , the current P/B ratio is approximately -25.26% higher. Relative to its 5-year average P/B ratio of 1.29, the current P/B ratio is about -45.40% higher. TrueBlue Inc (TBI) has a Forward Free Cash Flow (FCF) yield of approximately -23.27%. Compared to its 3-year average FCF yield of -2.42%, the current FCF yield is approximately 860.18% lower. Relative to its 5-year average FCF yield of 2.03% , the current FCF yield is about -1243.73% lower.
0.73
P/B
Median3y
0.94
Median5y
1.29
-24.02
FCF Yield
Median3y
-2.42
Median5y
2.03
Competitors Valuation Multiple
The average P/S ratio for TBI's competitors is 1.27, providing a benchmark for relative valuation. TrueBlue Inc Corp (TBI) exhibits a P/S ratio of 0.12, which is -90.44% above the industry average. Given its robust revenue growth of -8.09%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TBI decreased by 39.58% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -0.42 to -3.88.
The secondary factor is the Revenue Growth, contributed -8.09%to the performance.
Overall, the performance of TBI in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

CATX
Perspective Therapeutics Inc
3.880
USD
-1.02%

FUND
Sprott Focus Trust Inc
7.711
USD
-0.89%

FLYX
Flyexclusive Inc
2.250
USD
-3.85%

DOGZ
Dogness International Corp
7.760
USD
-4.90%

CIA
Citizens Inc
3.980
USD
-2.93%

FBLA
FB Bancorp Inc
11.780
USD
-1.01%

CRDF
Cardiff Oncology Inc
2.490
USD
-24.77%

AMRN
Amarin Corporation PLC
14.970
USD
+2.18%

BDMD
Baird Medical Investment Holdings Ltd
2.090
USD
+2.45%

CRD.B
Crawford & Co
9.580
USD
-2.44%
FAQ

Is TrueBlue Inc (TBI) currently overvalued or undervalued?
TrueBlue Inc (TBI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.13 is considered Undervalued compared with the five-year average of 15.41. The fair price of TrueBlue Inc (TBI) is between 14.53 to 24.31 according to relative valuation methord. Compared to the current price of 7.42 USD , TrueBlue Inc is Undervalued By 48.95% .

What is TrueBlue Inc (TBI) fair value?

How does TBI's valuation metrics compare to the industry average?

What is the current P/B ratio for TrueBlue Inc (TBI) as of Jul 31 2025?

What is the current FCF Yield for TrueBlue Inc (TBI) as of Jul 31 2025?

What is the current Forward P/E ratio for TrueBlue Inc (TBI) as of Jul 31 2025?
